HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Noninvasive de novo imaging of human embryonic stem cell-derived teratoma formation.

Abstract
Teratoma formation can be a serious drawback after the therapeutic transplantation of human embryonic stem (hES) cells. Therefore, noninvasive imaging of teratomas could be a valuable tool for monitoring patients undergoing hES cell treatment. Here, we investigated the angiogenic process within teratomas derived from hES cells and now report the first example of using (64)Cu-labeled RGD tetramer ((64)Cu-DOTA-RGD4) for positron emission tomography imaging of teratoma formation by targeting alpha(v)beta(3) integrin. H9 hES cells (2 x 10(6)), stably expressing firefly luciferase, and enhanced green fluorescence protein (Fluc-eGFP) were injected into adult nude mice (n=12) s.c. Eight weeks after transplantation, these hES cell grafts evolved into teratomas as confirmed by longitudinal bioluminescence imaging. Under micropositron emission tomography imaging, 2-deoxy-2-[(18)F]fluoro-D-glucose and 3'-deoxy-3'-[(18)F]-fluorothymidine both failed to detect hES cell-derived teratomas (0.8+/-0.5 versus 1.1+/-0.4 %ID/g, respectively; P=not significant versus background signals). By contrast, (64)Cu-DOTA-RGD4 revealed specific and prominent uptake in vascularized teratoma and significantly lower uptake in control tumors (human ovarian carcinoma 2008 cell line), which had low integrin expression (10.1+/-3.4 versus 1.4+/-1.2 %ID/g; P<0.01). Immunofluorescence staining of CD31 and beta(3) integrin also supported our in vivo imaging results (P<0.05). Moreover, we found that the cells dissociated from teratomas showed higher alpha(v)beta(3) integrin expression than the 2008 cells. In conclusion, by targeting alpha(v)beta(3) integrin, we successfully showed the ability of (64)Cu-DOTA-RGD4 to noninvasively visualize teratoma formation in vivo for the first time.
AuthorsFeng Cao, Zibo Li, Andrew Lee, Zhaofei Liu, Kai Chen, Hui Wang, Weibo Cai, Xiaoyuan Chen, Joseph C Wu
JournalCancer research (Cancer Res) Vol. 69 Issue 7 Pg. 2709-13 (Apr 01 2009) ISSN: 1538-7445 [Electronic] United States
PMID19318556 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Copper Radioisotopes
  • Heterocyclic Compounds, 1-Ring
  • Integrin alphaVbeta3
  • Oligopeptides
  • Organometallic Compounds
  • Radiopharmaceuticals
  • 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
  • arginyl-glycyl-aspartic acid
Topics
  • Animals
  • Cell Line, Tumor
  • Cell Transformation, Neoplastic (pathology)
  • Copper Radioisotopes (chemistry, pharmacokinetics)
  • Embryonic Stem Cells (diagnostic imaging, metabolism, pathology)
  • Endothelial Cells (pathology)
  • Female
  • Heterocyclic Compounds, 1-Ring (chemistry, pharmacokinetics)
  • Humans
  • Integrin alphaVbeta3 (biosynthesis, metabolism)
  • Mice
  • Mice, Nude
  • Neovascularization, Pathologic (diagnostic imaging, metabolism, pathology)
  • Oligopeptides (chemistry, pharmacokinetics)
  • Organometallic Compounds (chemistry, pharmacokinetics)
  • Ovarian Neoplasms (blood supply, diagnostic imaging, pathology)
  • Positron-Emission Tomography (methods)
  • Radiopharmaceuticals (chemistry, pharmacokinetics)
  • Teratoma (blood supply, diagnostic imaging, metabolism, pathology)
  • Transplantation, Heterologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: